Pyrroles
- (1)
- (84)
- (1)
- (6)
- (1)
- (5)
- (2)
- (6)
- (1)
- (13)
- (1)
- (3)
- (1)
- (14)
- (46)
- (3)
- (1)
- (1)
- (1)
- (6)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (4)
- (1)
- (1)
- (2)
- (1)
- (7)
- (1)
- (1)
- (7)
- (2)
- (1)
- (1)
- (1)
- (5)
- (3)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (9)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (1)
- (2)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (4)
- (1)
- (2)
- (1)
- (4)
- (1)
- (7)
- (1)
- (12)
- (4)
- (6)
- (1)
- (2)
- (1)
- (4)
- (10)
- (4)
- (58)
- (17)
- (10)
- (2)
- (1)
- (36)
- (1)
- (2)
- (9)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
Filtered Search Results
Medchemexpress LLC Nemonoxacin malate | 951163-60-3 | 99.3% | 505.52 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Nemonoxacin malate is a nonfluorinated quinolone antibiotic with broad-spectrum activity against various pathogens, including drug-resistant Streptococcus pneumoniae and Methicillin-resistant Staphylococcus aureus. It is used in research for community-acquired pneumonia.
- Nonfluorinated quinolone antibiotic
- Broad-spectrum activity against gram-positive, gram-negative, and atypical pathogens
- Inhibits drug-resistant *Streptococcus pneumoniae*
- Inhibits methicillin-resistant *Staphylococcus aureus*
- Used for research on community-acquired pneumonia
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Ripk1-in-10 | 2682889-51-4 | 98.25% | C30H28F2N6O4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
RIPK1-IN-10 is a potent inhibitor, identified as example 37, derived from patent WO2021160109. This compound is intended exclusively for research purposes.
- Potent RIPK1 inhibitor
- Suitable for research use only
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Pyrrole-2-carboxaldehyde | 1003-29-8 | 99.99% | C5H5NO | 25 G
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Pyrrole-2-carboxaldehyde (2-Formylpyrrole) is a five-membered N-heterocyclic system, acting as both a proton donor and acceptor. It displays unique vibrational and electronic characteristics, existing as a dimer in solid phase and a monomer in solution.
- Exhibits vibrational and electronic characteristics
- Exists as dimer in solid phase, monomer in solution
- Five-membered N-heterocyclic system
- Functions as proton donor and acceptor
- Solid, white to light brown appearance
- Store at 4°C, protected from light, under nitrogen
- Store in solvent: -80°C (6 months), -20°C (1 month)
- Soluble in DMSO (100 mg/mL) with sonication
- Suitable for various in vivo applications
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC N N -DME-N-PEG2-Boc | 50MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
N N -DME-N-PEG2-Boc | 50MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC TLR7/8-IN-1 | 2205095-75-4 | 99.92% | 532.68 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
TLR7/8-IN-1 is a crystalline form of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. It is intended for research use only and can be used for the research of autoimmune disease.
- Crystalline form of a TLR7/TLR8 inhibitor.
- Extracted from patent WO2019220390, compound 2b.
- Can be used for the research of autoimmune disease.
- Available in various solid quantities ranging from 1 mg to 100 mg.
- High purity of 99.92%.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin hemicalcium salt | 134523-03-8 | 99.9% | 577.67 | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin hemicalcium salt | 134523-03-8 | 99.9% | 577.67 | 5 MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin (hemicalcium salt) | 134523-03-8 | 99.9% | 577.67 | 500 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin hemicalcium salt is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor with blood-brain barrier permeability. It effectively decreases blood lipids and inhibits human SV-SMC proliferation and invasion. This compound reduces apoptosis of myocardial cells by down-regulating GRP78, caspase-12, and CHOP expression, and activates endoplasmic reticulum stress in response to heart failure and angiotensin II stimulation.
- Orally active HMG-CoA reductase inhibitor
- Blood-brain barrier permeable
- Decreases blood lipids
- Inhibits SV-SMC proliferation and invasion
- Reduces apoptosis of myocardial cells
- Activates endoplasmic reticulum stress response
- Inhibits proinflammatory cytokines
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin methyl ester | 345891-62-5 | MFCD21363420 | 98.8% | C34H37FN2O5 | 10MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin methyl ester is a methyl-esterified derivative of atorvastatin provided for laboratory research. It is used as a drug derivative and has been reported to inhibit 9-cis-RA-induced Gal4 reporter activity more strongly than atorvastatin. The compound is supplied as solids and as a DMSO solution for in vitro experiments.
- Methyl-esterified derivative of atorvastatin used for research
- Reported to inhibit 9-cis-RA-induced Gal4 reporter activity more strongly than atorvastatin
- Available as solid quantities (10 mg-500 mg) and 10 mM solution in DMSO
- High purity (approx. 98.8%) suitable for in vitro studies
- Useful structural analogue for metabolism and activity studies
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin hemicalcium salt | 134523-03-8 | MFCD00078759 | 99.9% | 1155.37 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin hemicalcium salt (CI-981) is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor with blood-brain barrier permeability. It is effective in decreasing blood lipids. The compound inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively.
- Orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor.
- Possesses blood-brain barrier permeability.
- Effectively decreases blood lipids.
- Inhibits human SV-SMC proliferation and invasion.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 625-82-1 | 2,4-Dimethyl-1H-pyrrole | ChemScene | MFCD00192088 | 95.145 | C6H9N | 95.000 | Cc1c[nH]c(C)c1 | 100g | 536855498
2,4-Dimethyl-1H-pyrrole | ChemScene | 625-82-1 | MFCD00192088 | 95.145 | C6H9N | 95.000 | Cc1c[nH]c(C)c1 | 100g | 536855498
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin | 134523-00-5 | 99.6% | 10 MM X 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin is an orally active HMG-CoA reductase inhibitor that effectively decreases blood lipids. It inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively.
- Acts as an HMG-CoA reductase inhibitor
- Effectively decreases blood lipids
- Inhibits human SV-SMC proliferation
- Inhibits human SV-SMC invasion
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin calcium salt trihydrate | 344423-98-9 | 99.8% | 605.71 | 1 G
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin calcium salt trihydrate is a drug belonging to the statin class of drugs used to lower blood cholesterol levels. Atorvastatin calcium salt trihydrate has unique chemical properties that make it an effective tool in controlling high levels of low-density lipoprotein (LDL) cholesterol and triglycerides in the body, reducing the risk of heart attack and stroke. Atorvastatin calcium salt trihydrate works by inhibiting HMG-CoA reductase, the enzyme responsible for producing cholesterol in the liver.
- Lowers blood cholesterol levels.
- Controls high levels of low-density lipoprotein (LDL) cholesterol and triglycerides.
- Reduces the risk of heart attack and stroke.
- Works by inhibiting HMG-CoA reductase, the enzyme responsible for producing cholesterol in the liver.
- Can be used as a biochemical reagent for life science-related research.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin (hemicalcium trihydrate) | 344920-08-7 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin hemicalcium trihydrate is an orally active inhibitor of HMG-CoA reductase. Its primary function is to effectively lower blood lipid levels. Additionally, it has been observed to inhibit human SV-SMC proliferation and invasion, with IC50 values of 0.39 μM and 2.39 μM, respectively.
- Orally active HMG-CoA reductase inhibitor
- Effectively decreases blood lipids
- Inhibits human SV-SMC proliferation and invasion
- Demonstrates IC50s of 0.39 μM (proliferation) and 2.39 μM (invasion) in human SV-SMC
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Pyrrole-2-carboxaldehyde | 1003-29-8 | 99.99% | C₅H₅NO | 1 G
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Pyrrole-2-carboxaldehyde (2-Formylpyrrole) is a five-membered N-heterocyclic system that exhibits distinct vibrational and electronic characteristics. It is observed in a dimeric form in the solid phase and a monomeric form in solution.
- Five-membered N-heterocyclic system
- Pyrrole group acts as a proton donor
- Carbonyl group functions as a proton acceptor
- Exhibits vibrational and electronic characteristics
- Exists as a dimeric form in the solid phase
- Exists as a monomeric form in solution
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 941714-57-4 | methyl 3-bromo-1H-pyrrole-2-carboxylate | Pharmablock | MFCD23106341 | 204.023 | C6H6BrNO2 | 97.000 | COC(=O)c1[nH]ccc1Br | 10g | 551311044
methyl 3-bromo-1H-pyrrole-2-carboxylate | Pharmablock | 941714-57-4 | MFCD23106341 | 204.023 | C6H6BrNO2 | 97.000 | COC(=O)c1[nH]ccc1Br | 10g | 551311044
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More